Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Green

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Pediatric Dermatology|March 10, 2020
Long-term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44-week open-label extension studyAdelaide A Hebert, Dee Anna Glaser, Lawrence Green, et al.
The Journal of Dermatological Treatment|July 25, 2017
Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasisSteven R Feldman, Lawrence Green, Alexa B Kimball, et al.
Dermatology and Therapy|February 9, 2024
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor)Melinda Gooderham, Ronald Vender, Jeffrey Crowley, et al.
Journal of Drugs in Dermatology : JDD|August 9, 2023
Consensus Statements on the Use of Corticosteroid-Containing Topical Medications in PsoriasisApril W Armstrong, Rasika Reddy, Samiya Khan, et al.
Pediatric Dermatology|November 20, 2018
Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trialsAdelaide A Hebert, Dee Anna Glaser, Lawrence Green, et al.
The Journal of Dermatological Treatment|July 14, 2022
Efficacy and tolerability of three topical acne treatments by body mass index: post hoc analysis including overweight and obese patientsJonette Keri, Fran E Cook-Bolden, Lawrence Green, et al.
The Journal of Clinical and Aesthetic Dermatology|August 9, 2022
A Randomized, Controlled Trial of Trifarotene Plus Doxycycline for Severe Acne VulgarisJames Q Del Rosso, Sandra Marchese Johnson, Todd Schlesinger, et al.
Journal of the American Academy of Dermatology|July 14, 2018
Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trialsDee Anna Glaser, Adelaide A Hebert, Alexander Nast, et al.
Journal of Drugs in Dermatology : JDD|July 2, 2011
Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgarisEmil Tanghetti, Sunil Dhawan, Lawrence Green, et al.
American Journal of Clinical Dermatology|May 22, 2019
A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary HyperhidrosisDee Anna Glaser, Adelaide A Hebert, Alexander Nast, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Pediatric Dermatology|March 10, 2020
Long-term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44-week open-label extension studyAdelaide A Hebert, Dee Anna Glaser, Lawrence Green, et al.
The Journal of Dermatological Treatment|July 25, 2017
Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasisSteven R Feldman, Lawrence Green, Alexa B Kimball, et al.
Dermatology and Therapy|February 9, 2024
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor)Melinda Gooderham, Ronald Vender, Jeffrey Crowley, et al.
Journal of Drugs in Dermatology : JDD|August 9, 2023
Consensus Statements on the Use of Corticosteroid-Containing Topical Medications in PsoriasisApril W Armstrong, Rasika Reddy, Samiya Khan, et al.
Pediatric Dermatology|November 20, 2018
Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trialsAdelaide A Hebert, Dee Anna Glaser, Lawrence Green, et al.
The Journal of Dermatological Treatment|July 14, 2022
Efficacy and tolerability of three topical acne treatments by body mass index: post hoc analysis including overweight and obese patientsJonette Keri, Fran E Cook-Bolden, Lawrence Green, et al.
The Journal of Clinical and Aesthetic Dermatology|August 9, 2022
A Randomized, Controlled Trial of Trifarotene Plus Doxycycline for Severe Acne VulgarisJames Q Del Rosso, Sandra Marchese Johnson, Todd Schlesinger, et al.
Journal of the American Academy of Dermatology|July 14, 2018
Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trialsDee Anna Glaser, Adelaide A Hebert, Alexander Nast, et al.
Journal of Drugs in Dermatology : JDD|July 2, 2011
Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgarisEmil Tanghetti, Sunil Dhawan, Lawrence Green, et al.
American Journal of Clinical Dermatology|May 22, 2019
A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary HyperhidrosisDee Anna Glaser, Adelaide A Hebert, Alexander Nast, et al.
Pageof 6